Status:
RECRUITING
Does Pancreatic Stent Decrease the Risk of Pancreatitis After Pancreatic Sphincterotomy for Difficult Cannulation?
Lead Sponsor:
Helsinki University Central Hospital
Conditions:
Endoscopic Retrograde Cholangiopancreatography
Eligibility:
All Genders
18-100 years
Phase:
NA
Brief Summary
The purpose of the study is to compare the risk of PEP after pancreatic sphincterotomy performed for difficult cannulation in a group of patients with and in a group of patients without placement of a...
Eligibility Criteria
Inclusion
- Consecutive patients with naïve papilla presenting to ERCP with indication of common bile duct (CBD) cannulation will be considered to the study.
Exclusion
- Exclusion criteria are age below 18 years, acute pancreatitis and no consent to the study.
Key Trial Info
Start Date :
August 1 2020
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 1 2024
Estimated Enrollment :
268 Patients enrolled
Trial Details
Trial ID
NCT04408482
Start Date
August 1 2020
End Date
September 1 2024
Last Update
February 28 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Helsinki Univeristy Hospital
Helsinki, Finland